Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Calcif Tissue Int

Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Retic REDinREN-ISCIII, Avda. Roma, sn., 33011, Oviedo, Spain.

Published: April 2021

The key players of the chronic kidney disease-mineral and bone disorders (CKD-MBD) are calcium, phosphate, PTH, FGF23, and the vitamin D hormonal system. The progressive reduction of kidney function greatly modifies the tightly interrelated mechanisms that control these parameters. As a result, important changes occur in the bone and mineral hormonal axis, leading to changes in bone turnover with relevant consequences in clinical outcomes, such as decrease in bone mass with increased bone fragility and bone fractures and increased vascular and valvular calcification, also with great impact in the cardiovascular outcomes. So far, the knowledge of the mineral and bone disorders in CKD and the increased variety of efficacious therapies should lead to a better prevention and management of CKD-MBD.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-020-00777-1DOI Listing

Publication Analysis

Top Keywords

bone disorders
12
chronic kidney
8
kidney disease-mineral
8
bone
8
disease-mineral bone
8
disorders pathogenesis
4
pathogenesis management
4
management key
4
key players
4
players chronic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!